Konjac mannan

DB14963InvestigationalSmall molecule

Konjac mannan is under investigation in clinical trial NCT01709955 (The Effects of Glucomannan on Weight Loss).

Mechanism: Pharmacologically active on Toll-like receptor 2
Curator reviewed
Also known as: GLUCOMANNAN

Resolves to

Compound

Clinical / RWD

Targets

What you can answer from here — as of September 02, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

402Drug interactionsStructured to mechanism, not free text

2Clinical trialsPhase, status and sponsor resolved per trial

2Marketed productsAcross 1 country and 1 labeller

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Konjac mannan, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.